Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience

May 1, 2003
Darren Kocs, MD, MHSA
Darren Kocs, MD, MHSA

,
A. Mark Fendrick, MDS
A. Mark Fendrick, MDS

Volume 9, Issue 5